Cancer-Related Mutations in the Sam Domains of EphA2 Receptor and Ship2 Lipid Phosphatase: A Computational Study
The lipid phosphatase Ship2 interacts with the EphA2 receptor by forming a heterotypic Sam (sterile alpha motif)–Sam complex. Ship2 works as a negative regulator of receptor endocytosis and consequent degradation, and anti-oncogenic effects in cancer cells should be induced by hindering its associat...
Main Authors: | Marian Vincenzi, Flavia Anna Mercurio, Ida Autiero, Marilisa Leone |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/29/5/1024 |
Similar Items
-
Hunting for Novel Routes in Anticancer Drug Discovery: Peptides against Sam-Sam Interactions
by: Flavia Anna Mercurio, et al.
Published: (2022-09-01) -
Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
by: Hatano Manabu, et al.
Published: (2004-11-01) -
EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer
by: Robiya Joseph, et al.
Published: (2024-01-01) -
EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
by: Mario Cioce, et al.
Published: (2021-02-01) -
Inhibition of EphA2 by Dasatinib Suppresses Radiation-Induced Intestinal Injury
by: Areumnuri Kim, et al.
Published: (2020-11-01)